Publications by authors named "Hirokazu Komoriyama"

Background: Because it is unclear whether implantable cardioverter-defibrillators (ICDs) are equally effective in patients of all ages, we investigated the association of age with long-term clinical outcomes of patients who underwent ICD implantation.

Methods And Results: A total of 416 consecutive patients (mean age: 69 years) from 4 tertiary hospitals who underwent ICD implantation or were upgraded from an existing permanent pacemaker between January 2011 and November 2022 were enrolled and divided into 3 groups based on age: <65 years (n=158), 65-74 years (n=138), and ≥75 years (n=120). We compared the incidence of all-cause death and adverse cardiovascular events, including cardiac death, appropriate ICD therapy, and heart failure hospitalization.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers aimed to create a machine learning tool to automatically assess frailty in elderly heart failure patients, addressing the inconsistency of subjective frailty scales.
  • The study involved 417 patients aged 75 and older, using smartphone technology to analyze body motion and determine frailty scores based on key physical features.
  • Results showed that the machine learning model demonstrated strong agreement with actual frailty assessments and that higher frailty scores predicted an increased risk of death over a follow-up period.
View Article and Find Full Text PDF
Article Synopsis
  • - The study investigated the link between long-term cardiac troponin levels and adverse events in patients with cardiac sarcoidosis who were treated with prednisolone, involving 63 patients and 463 troponin measurements over about 30 months.
  • - Results indicated that a higher cumulative level of troponin over time correlated with a greater risk of serious heart-related issues, such as ventricular tachycardia or sudden cardiac death, occurring in about 19% of patients.
  • - The findings suggest that monitoring troponin levels regularly could help identify patients at higher risk for adverse cardiac events, indicating its potential value in clinical settings.
View Article and Find Full Text PDF

Fragmented QRS (fQRS) on a 12-lead electrocardiogram is a known marker of fatal arrhythmias or cardiac adverse events in ischemic and non-ischemic cardiomyopathy patients. Nonetheless, the association between fQRS and clinical outcomes in patients with cardiac sarcoidosis (CS) remains unclear. Herein, we investigated whether fQRS is associated with long-term clinical outcomes in CS patients.

View Article and Find Full Text PDF

Aims: Although soluble interleukin 2 receptor (sIL-2R) is a potentially useful biomarker in the diagnosis and evaluation of disease severity in patients with sarcoidosis, its prognostic implication in patients with cardiac sarcoidosis (CS) is unclear. We sought to investigate whether sIL-2R was associated with clinical outcomes and to clarify the relationship between sIL-2R levels and disease activity in patients with CS.

Methods And Results: We examined 83 consecutive patients with CS in our hospital who had available serum sIL-2R data between May 2003 and February 2020.

View Article and Find Full Text PDF

Acute myocardial infarction (AMI) caused by severe stenosis of left main coronary artery (LMCA) presenting with cardiogenic shock and pulmonary edema during noncardiac surgery is uncommon, but a catastrophic event. A 77-year-old male with cholangiocarcinoma underwent hepatectomy. During the surgery, he presented with cardiogenic shock, which did not respond to infusion administration or vasopressor.

View Article and Find Full Text PDF

Background: Diagnosing heart failure with preserved ejection fraction (HFpEF) is challenging. Although the HFPEF score and HFA-PEFF algorithm have been proposed for diagnosing HFpEF, previous validation studies were conducted in stable chronic heart failure (HF). Moreover, information on their applicability in the Asian population is limited.

View Article and Find Full Text PDF

Objectives: This study aimed to assess, among Japanese patients with cardiac sarcoidosis (CS), the implantable cardioverter-defibrillator (ICD) recommendations from the 2017 American Heart Association/American College of Cardiology/Heart Rhythm Society (AHA/ACC/HRS) guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death (SCD).

Background: Although ICDs are used to prevent SCD from ventricular tachycardia or ventricular fibrillation (VT/VF) in patients with CS, the generalizability of the AHA/ACC/HRS guidelines for Japanese patients with CS remains unclear.

Methods: This study examined 188 consecutive patients with CS in 2 tertiary hospitals between 1979 and 2020.

View Article and Find Full Text PDF

Background: Pre- and post-procedural hemodynamic changes which could affect adverse outcomes in aortic stenosis (AS) patients who undergo transcatheter aortic valve replacement (TAVR) have not been well investigated. Four-dimensional (4D) flow cardiovascular magnetic resonance (CMR) enables accurate analysis of blood flow dynamics such as flow velocity, flow pattern, wall shear stress (WSS), and energy loss (EL). We sought to examine the changes in blood flow dynamics of patients with severe AS who underwent TAVR.

View Article and Find Full Text PDF

Cardiac sarcoidosis (CS) is frequently complicated by fatal ventricular arrhythmias. T-peak to T-end interval to QT interval ratio (TpTe/QT) on electrocardiograms (ECG) was proposed as a marker of ventricular repolarization dispersion. Although this ratio could be associated with the incidence of ventricular arrhythmias in cardiovascular diseases, its prognostic implication in patients with CS is unclear.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the link between serum magnesium levels upon admission and in-hospital mortality in patients with acute myocardial infarction complicated by out-of-hospital cardiac arrest and malignant ventricular arrhythmias.
  • A retrospective analysis of 165 patients showed that higher serum magnesium levels were significantly associated with an increased risk of in-hospital death and other severe complications.
  • The findings suggest that monitoring serum magnesium levels could help predict outcomes in similar high-risk patients.
View Article and Find Full Text PDF

Background: The histopathological diagnosis of cardiac sarcoidosis (CS) is challenging because of sampling error in endomyocardial biopsy (EMB) and the determinants of positive EMB are unclear. Reduced left ventricular ejection fraction (LVEF) is a simple parameter of the extent of myocardial damage, and higher serum angiotensin-converting enzyme (ACE) activity would indicate the spread of disease activity in CS patients. Thus, we sought to examine whether these parameters are related to the histopathological diagnosis of CS by EMB.

View Article and Find Full Text PDF

Elevated serum uric acid (UA) is associated with an increased risk of cardiovascular disease and worse clinical outcome in patients with cardiovascular disease. Nevertheless, the prognostic value of serum UA level in hospitalized heart failure patients with preserved ejection fraction (HFpEF) has not been fully elucidated. The aim of this study was to investigate whether serum UA level on admission could be associated with subsequent mortality in hospitalized patients with HFpEF.

View Article and Find Full Text PDF

Aims: The prognostic implication of left ventricular outflow tract velocity time integral (LVOT-VTI) on admission in hospitalized heart failure with preserved ejection fraction (HFpEF) patients has not been determined. We sought to investigate whether LVOT-VTI on admission is associated with worse clinical outcomes in hospitalized patients with HFpEF.

Methods And Results: We studied consecutive 214 hospitalized HFpEF patients who had accessible LVOT-VTI data on admission, from a prospective HFpEF-specific multicentre registry.

View Article and Find Full Text PDF

Background: Doppler-estimated peak systolic tricuspid regurgitation pressure gradient (TRPG) is a representative noninvasive parameter for evaluating pulmonary artery systolic pressure, which can be a determinant of adverse outcomes in chronic heart failure with preserved ejection fraction (HFpEF). However, the prognostic implications of TRPG at admission for hospitalized patients with HFpEF are undetermined.

Methods And Results: We examined 469 consecutive hospitalized patients with decompensated HFpEF (left ventricular ejection fraction ≥ 50%) who underwent TRPG measurement at admission in our HFpEF multicenter registry.

View Article and Find Full Text PDF